Public Submission Instructions

Abstract Submission 

The EAN has long been known as Europe’s Home of Neurology, and this year the EAN Congress 2027 brings together the global neurology community in Gothenburg, Sweden, from 12–15 June, under the theme Transforming Neurology: Embracing Every Brain. 
 
The Congress is a unique opportunity for us to share our latest research, exchange scientific insights, and connect with colleagues from around the world! 

If you're eager to present your groundbreaking research through an oral or poster presentation or poster display, this year's event is the ideal opportunity to share your new discoveries, inspire new ideas and foster collaboration with our dedicated neurology community. 

Don't miss out on this opportunity to be a part of something truly impactful! 

Important points to remember 

  1. Keep your MyEAN profile up to date. Log in or create an account here. 
  2. Review the submission requirements carefully. Please familiarise yourself with the submission deadlines, guidelines, and available topics before submitting your abstract. 
  3. Abstracts must be submitted online via the EAN 2027 Abstract Submission Portal. 
  4. Ensure the presenting author is registered. If your abstract is accepted, the designated presenting author must be registered for the Congress. 

Important Dates

Public Abstract Submission Opening Thursday 29 October 2026
Abstract Submission Deadline Thursday 14 January 2027, 23:59 CEST
Abstract Review Mid-February 2027
Notification of Acceptance/Rejection Mid-March 2027
Presenting Author Registration Deadline Wednesday 14 April 2027
Abstract Modification Deadline Wednesday 14 April 2027
Late-breaking Abstract Submission Opening Thursday 1 April 2027
Presentation Upload Opening Mid-May 2027
Late-breaking Abstract Submission Deadline Wednesday 5 May 2027, 23:59 CEST
Notification of Late-Breaking Acceptance/Rejection Mid-May 2027
Presentation Upload Deadline Wednesday 9 June 2027, 23:59 CEST
Lift of Abstract Embargo Friday 11 June 2027 18:30 CEST
EAN 2027 Congress Saturday 12 June - Tuesday 15 June 2027

EAN 2027: Guidelines for Abstract Submission

  • Abstracts must be submitted through an active MyEAN profile. Abstracts submitted via email will not be accepted. 
  • All co-authors' affiliations must be stated during the abstract submission. By submitting an abstract, the submitter gives full consent on behalf of all co-authors to provide their data. 
  • Abstracts must be submitted and presented in English. Ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced as submitted. 
  • Abstracts must contain new and original information that has not published elsewhere prior to 11 June 2027, 18:30 CEST. 
  • During abstract submission, authors must select one preferred presentation type: 
    • Oral presentation 
    • Poster presentation  
    • Poster or Oral presentation 
    • Poster Display 
  • Abstracts must be structured under the given headings: 
    • Introduction 
    • Methods 
    • Results 
    • Conclusion 
    • Disclosures - In the interest of transparency, disclose all relationships/activities/interests related to your manuscript 
  • Abstract titles may contain a maximum of 25 words and 150 characters including spaces. Abstract text (Introduction, Methods, Results and Conclusion) cannot exceed 250 words in total and 1500 characters per section. 
  • All abbreviations used must be written out at first use. 
  • Simplify complex mathematical formulas. Avoid symbols (Greek, mathematical, etc.). E.g. Instead of IFN-ß, use IFN-beta; instead of 10², use 10^2; instead of x≥2, use x>=2. 
  • A maximum of 3 images can be inserted per abstract. Images can only be submitted in JPG, JPEG or PNG format. The maximum size of all figures/tables is 10 MB. EAN may adjust tables or figures to fit for final publication. Tables must be submitted as a separate graphic file. Tables and images do not affect word count. 
  • If your research has been granted any commercial or institutional support, you will be asked to list these under Disclosures in the submission process. Prepare a one-sentence statement for this purpose. Disclosure text may contain a maximum of 3000 characters. 
  • Abstracts that are submitted or are currently under review cannot be edited directly through the submission portal. To request a correction, contact abstracts(at)ean.org and provide the relevant abstract ID (A-##-#####).  
  • Submitters may request modifications until Wednesday, April 14. Beyond this deadline, no further changes will be accepted, and abstracts will be published exactly as submitted. 
  • During the standard abstract submission, the bursary and tournament (basic or clinical research) application options are available only if the indicated presenting author is an active Resident and Research Member (RRFS) or Student Member at EAN. The bursary and tournaments options are not available for late-breaking abstract submissions.  
  • Presenting authors must have active MyEAN accounts under the submitted email address. Every presenting author can present a maximum of 3 abstracts. The submission system will alert the submitter if the selected presenting author has already been assigned 3 abstracts.  
  • Within one hour of submission, only the submitter will receive a confirmation email containing a unique abstract ID. If the confirmation email is not received within this timeframe, please contact abstracts(at)ean.org. The submitter is responsible for informing all authors about the abstract submission and review status. In the submission system, “Stage” is the stage of submission, and “Status” is the status of abstract review. Make sure to include the abstract ID in all communications with EAN Head Office. 
  • Where authors use generative AI and AI-assisted technologies in the writing process, these technologies should only be used to improve readability and language of the work. Applying the technology should be done with human oversight and control and authors should carefully review and edit the result, because AI can generate authoritative-sounding output that can be incorrect, incomplete, or biased. The authors are ultimately responsible and accountable for the contents of the work. 
  • Authors should disclose the use of AI and AI-assisted technologies by ticking the relevant checkbox during the abstract submission process. 
  • Authors should not list AI and AI-assisted technologies as an author or co-author, nor cite AI as an author. Authorship implies responsibilities and tasks that can only be attributed to and performed by humans. Authors are also responsible for ensuring that the work is original. 
  • All submitted abstracts will be screened using anti-plagiarism software, then reviewed by the Ethics and Quality Task Force to determine eligibility for further consideration. Shortlisted abstracts will be evaluated by an expert panel of reviewers and the Programme Committee, who will make the final decision on inclusion in the annual EAN Congress Programme. 
  • Only the abstract submitter will receive a notification regarding the outcome of the abstract review. The submitter is responsible for informing all authors, co-authors, and designated presenters about the stage and status of the abstract. 
  • Once an abstract is accepted, the presenting author must register for the congress. A penalty may be incurred if the presenting author, indicated at submission, does not register for congress, or does not attend the session for which (s)he has been scheduled. Not registering in time risks the omission of your accepted abstract from the Congress Programme. 

FAQs

 In case of any questions, head over to FAQs.

Presentation Types

Abstract Topics

  1. Ageing and dementia 
  2. Autonomic nervous system diseases 
  3. Cerebrovascular diseases 
  4. Child neurology/developmental neurology 
  5. Clinical neurophysiology 
  6. Cognitive neurology/neuropsychology 
  7. Coma and chronic disorders of consciousness 
  8. Education in neurology 
  9. Environmental Neurology/Climate Change 
  10. Epilepsy 
  11. Ethics in neurology 
  12. Headache 
  13. Higher cortical functions 
  14. History of neurology 
  15. Infectious diseases 
  16. Motor neurone diseases 
  17. Movement disorders 
  18. MS and related disorders 
  19. Muscle and neuromuscular junction disorder 
  20. Neurocritical care 
  21. Neuroepidemiology 
  22. Neurogenetics 
  23. Neuroimaging 
  24. Neuroimmunology 
  25. Neuroinformatics 
  26. Neurological manifestation of systemic diseases 
  27. Neurology and arts 
  28. Neuro-oncology 
  29. Neuro-ophthalmology/ neuro-otology 
  30. Neuropathies 
  31. Neurorehabilitation 
  32. Neurosonology 
  33. Neurotoxicology/occupational neurology 
  34. Neurotraumatology 
  35. Pain 
  36. Palliative care 
  37. Peripheral nerve disorders 
  38. Sleep-wake disorders 
  39. Spinal cord and root disorders